Back to search
Spinocerebellar Ataxia Genotype Type 1
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Spinocerebellar Ataxia Genotype Type 1 trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Spinocerebellar Ataxia Genotype Type 1 trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to evaluate the safety and feasibility of deep brain stimulation (DBS) in the deep cerebellar nuclei (DCN) in patients with Spinoce…
The primary purpose of this study was to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment…